Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Sell
8,689
-267
-3% -$31.3K 0.37% 65
2026
Q1
$999K Buy
8,956
+60
+0.7% +$6.93K 0.36% 69
2025
Q4
$1.04M Buy
8,896
+376
+4% +$35.3K 0.4% 69
2025
Q3
$766K Hold
8,520
– – 0.33% 74
2025
Q2
$682K Sell
8,520
-295
-3% -$23.4K 0.32% 79
2025
Q1
$686K Sell
8,815
-6,899
-44% -$644K 0.36% 73
2024
Q4
$1.56M Buy
+15,714
New +$1.62M 0.61% 49

Other funds holding MRK

Compass Capital Corp's MRK Position: Q2 2026 in Review

Compass Capital Corp reduced its Merck (MRK) stake by 3% in Q2 2026, selling an estimated $31.3K and leaving 8,689 shares worth $1.14M. The position accounts for 0.37% of the portfolio, ranked #65.

Compass Capital Corp first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.56M in Q4 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Compass Capital Corp held 8,689 shares of Merck worth $1.14M as of Q2 2026.
  • Compass Capital Corp sold 267 Merck shares in Q2 2026, an estimated $31.3K.
  • Merck made up 0.37% of Compass Capital Corp's portfolio in Q2 2026, its #65 holding.
  • Compass Capital Corp first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Compass Capital Corp's Merck position peaked at $1.56M in Q4 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Compass Capital Corp's 13F filing for Q2 2026, filed 13 Aug 2026.